Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
Superinvestors holding RVMD, Q2 2026
1 superinvestor reports holding Revolution Medicines, Inc. on Form 13F, worth $74.8M in total. Weight is Revolution Medicines, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Duquesne Family OfficeStanley Druckenmiller | 1.7% | 399,587 | $74.8M | Added+26.5% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RVMD each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- Duquesne Family Office (+26.5%)
Q1 2026
1 superinvestor holding at quarter end